Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Sirnagen Therapeutics Inc.

Clinical trials sponsored by Sirnagen Therapeutics Inc., explained in plain language.

Now part of OliX Pharmaceuticals, Inc. 226950 KOSDAQ

A clinical-stage biopharmaceutical company developing RNAi-based therapies for rare diseases.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1

New drug SRN001 takes first step toward fighting lung scarring

Knowledge-focused Recruiting now

This Phase 1 trial tests the safety and tolerability of an investigational drug called SRN001 in 30 healthy Korean and Caucasian men. Participants receive either SRN001 or a placebo to see how the drug moves through the body and whether it causes side effects. The goal is to gath…

Phase: PHASE1 • Sponsor: siRNAgen Therapeutics Inc. • Aim: Knowledge-focused

Last updated Jun 27, 2026 09:05 UTC